NMA: Nonprescription Medicines Academy

New Product Alerts

April 17th, 2013

Oxytrol for Women
The FDA has approved Oxytrol for Women (oxybutynin), the first nonprescription treatment for overactive bladder in women ages 18 years and older. It is expected be available in stores by September 2013. Oxytrol remains available for men with overactive bladder by prescription only.

Overactive bladder affects an estimated 33 million Americans, the majority of whom are older women. Oxytrol for Women is a transdermal patch that is applied to the skin every 4 days. The patch delivers 3.9 mg oxybutynin per day. Side effects reported during clinical studies were mild and included skin irritation where the patch was applied, dry mouth, and constipation. Additional information is available at www.oxytrolforwomen.com.

Sunscreen Bands
JADS International has marketed Sunscreen Bands—disposable wristbands with embedded photochromic dyes that change color when exposed to UV radiation. The band is pink when removed from the package and turns dark purple when it is first exposed to the sun for 5 minutes. After the band turns dark purple, users are directed to apply sunscreen to the band (after already having applied sunscreen to the exposed skin areas before going outside). The band turns light purple when it is time to reapply sunscreen; sun exposure should end when the band turns pale yellow/white. Bands should be discarded at the end of the day. Additional information is available at www.sunscreenbands.com.